Metformin Hydrochloride Prolonged Release & Glimepiride Tablets I.P. – GLUMIGHT M2 FORTE Tablets

Glumight M2 Forte
Composition: Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P.

Glumight M2 Forte — Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P. is used for the management of type 2 diabetes mellitus. Metformin prolonged-release helps control blood sugar by reducing glucose production and improving insulin sensitivity, while glimepiride stimulates insulin release from the pancreas. Together, they provide effective and sustained glycemic control, helping maintain stable blood sugar levels and reducing the risk of long-term diabetes-related complications when taken regularly with proper diet and lifestyle.

key Points of Metformin Hydrochloride Prolonged Release & Glimepiride Tablets I.P. – GLUMIGHT M2 FORTE Tablets : Advanced Combination for Complete Blood Sugar Control

Active Ingredients:

• Metformin Hydrochloride (Prolonged-Release) — Biguanide antidiabetic agent
• Glimepiride — Sulfonylurea

Therapeutic Benefits: Helps manage type 2 diabetes mellitus by improving insulin sensitivity and increasing insulin secretion. Supports effective control of both fasting and post-meal blood glucose levels, contributing to overall glycaemic stability.
Better Tolerability: The prolonged-release Metformin formulation allows gradual drug release, helping reduce gastrointestinal discomfort and supporting better patient compliance when used under medical supervision.
Mode of Action: Metformin (PR) reduces glucose production in the liver and enhances insulin sensitivity, while Glimepiride stimulates insulin release from pancreatic beta cells—together providing effective and sustained blood sugar control.

Can be prescribed by:

• Diabetologists
• Endocrinologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used strictly under the guidance of a qualified healthcare professional. For prescription use only. Not intended for public marketing or promotion only.